• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期药代动力学/药效学建模方法。

Approaches to pharmacokinetic/ pharmacodynamic modeling during pregnancy.

作者信息

Wyska E, Jusko W J

机构信息

Department of Pharmaceutical Sciences, State University of New York at Buffalo, USA.

出版信息

Semin Perinatol. 2001 Jun;25(3):124-32. doi: 10.1053/sper.2001.24905.

DOI:10.1053/sper.2001.24905
PMID:11453607
Abstract

The modern approach in the field of pharmacokinetics/pharmacodynamics is the development of models based on the mechanisms of drug action and their alteration of physiologic processes. Such models often require consideration of the input and disposition kinetics of the drug, distribution to sites of action (biophase), processes controlling receptor binding or mediator turnover, mechanisms of drug activity, and signal transduction steps. Responses can often be categorized as: Direct (rapidly or slowly reversible), Indirect (inhibitory or stimulatory), or Irreversible. Further, there may be alterations in the system owing to tolerance, counter-regulation, pathophysiology, or physiological changes such as gender or pregnancy. Mathematical and computational tools are necessary for processing data. This article overviews many available pharmacodynamic models with an indication of the diverse approaches for quantitation of pharmacologic responses. Examples from the literature are illustrated with emphasis on changes occurring in kinetics and dynamics during pregnancy.

摘要

药代动力学/药效学领域的现代方法是基于药物作用机制及其对生理过程的改变来开发模型。此类模型通常需要考虑药物的输入和处置动力学、药物作用部位(生物相)的分布、控制受体结合或介质周转的过程、药物活性机制以及信号转导步骤。反应通常可分为:直接(快速或缓慢可逆)、间接(抑制性或刺激性)或不可逆。此外,由于耐受性、反调节、病理生理学或诸如性别或妊娠等生理变化,系统可能会发生改变。处理数据需要数学和计算工具。本文概述了许多可用的药效学模型,并指出了定量药理反应的不同方法。文中列举了文献中的实例,重点阐述了妊娠期间动力学和动态变化情况。

相似文献

1
Approaches to pharmacokinetic/ pharmacodynamic modeling during pregnancy.孕期药代动力学/药效学建模方法。
Semin Perinatol. 2001 Jun;25(3):124-32. doi: 10.1053/sper.2001.24905.
2
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.从基础到系统药效动力学模型的转变:皮质类固醇的经验教训。
Pharmacol Rev. 2020 Apr;72(2):414-438. doi: 10.1124/pr.119.018101.
3
Diversity of mechanism-based pharmacodynamic models.基于机制的药效学模型的多样性。
Drug Metab Dispos. 2003 May;31(5):510-8. doi: 10.1124/dmd.31.5.510.
4
Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.理解药代动力学/药效动力学关系中的滞后环难题。
J Pharm Pharm Sci. 2014;17(1):34-91.
5
Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.基于机制的药代动力学-药效学建模:生物相分布、受体理论和动力学系统分析。
Annu Rev Pharmacol Toxicol. 2007;47:357-400. doi: 10.1146/annurev.pharmtox.47.120505.105154.
6
Pharmacokinetic and pharmacodynamic modeling in vivo.体内药代动力学和药效学建模
Crit Rev Bioeng. 1981;5(4):273-322.
7
Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.Maxsim2-用于计算机辅助药代动力学和药效学教学的实时交互式模拟。
Comput Methods Programs Biomed. 2014 Mar;113(3):815-29. doi: 10.1016/j.cmpb.2013.12.006. Epub 2013 Dec 25.
8
Pharmacodynamic model of slow reversible binding and its applications in pharmacokinetic/pharmacodynamic modeling: review and tutorial.慢可逆结合药效动力学模型及其在药代动力学/药效动力学建模中的应用:综述与教程。
J Pharmacokinet Pharmacodyn. 2022 Oct;49(5):493-510. doi: 10.1007/s10928-022-09822-y. Epub 2022 Aug 30.
9
Pharmacokinetic-pharmacodynamic modelling: history and perspectives.药代动力学-药效学建模:历史与展望
J Pharmacokinet Pharmacodyn. 2006 Jun;33(3):227-79. doi: 10.1007/s10928-005-9002-0. Epub 2006 Jan 11.
10
Considerations on pharmacodynamics and pharmacokinetics: can everything be explained by the extent of drug binding to its receptor?
Can J Physiol Pharmacol. 2000 Mar;78(3):199-207.

引用本文的文献

1
Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV).直接抗病毒药物(DAA)及其在丙型肝炎(HCV)孕妇中的应用。
Expert Rev Anti Infect Ther. 2022 Nov;20(11):1413-1424. doi: 10.1080/14787210.2022.2125868. Epub 2022 Sep 20.
2
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel.推动在结核病药物试验中更早纳入孕妇和产后妇女:国际专家小组的共识声明
Clin Infect Dis. 2016 Mar 15;62(6):761-769. doi: 10.1093/cid/civ991. Epub 2015 Dec 9.